COSENTYX

Google image searchProduct monograph

Active ingredient

secukinumab, 75 MG/0.5 ML

DIN: 02525569

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: SINGLE USE PREFILLED SYRINGE

Schedule: Prescription / Schedule D

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 02-JUN-2022

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AC — Interleukin inhibitors (ATC, ATC/DDD)
• L04AC10 — SECUKINUMAB (ATC/DDD)

External Links for Cosentyx

Search on Google

• Cosentyx side effects
• Cosentyx dosage
• secukinumab side effects
• secukinumab dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find cosentyx photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.